The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research

Chronic Airway Diseases Early Stratification (CADSET): a new ERS Clinical Research Collaboration

“…The long-term goal of WG5 is to integrate the age-related results of WG2, WG3 and WG4, so that the strategic goals of CADSET can be fulfilled. CADSET will collaborate with other established CRCs, such as SHARP (The Severe Heterogeneous Asthma Research collaboration, Patient-centred) [5] and the Global Lung Function Initiative (GLI) network [10].…”

“…These have the aim of 1) promoting the exchange of research ideas among clinicians and affiliated scientists in Europe and/or globally; 2) building an infrastructure for prospective clinical research; 3) securing additional funding through national and European Union funding streams; and 4) facilitating the planning, implementation, evaluation and publication of clinical and translational studies at pan-European level and beyond. So far, there are currently 17 ongoing CRCs that cover eight major respiratory disease domains (airway diseases, interstitial lung diseases, pulmonary vascular diseases, sleep and breathing disorders, respiratory critical care, paediatric respiratory diseases, respiratory infections and thoracic oncology), all of them linked to one or more ERS assemblies [2][3][4][5][6][7][8][9][10][11][12]. CADSET, an acronym that stands for "Chronic Airway Diseases Early Stratification", is the latest addition to the list of ongoing CRCs (www.…”

New understanding in the treatment of cough (NEUROCOUGH) ERS Clinical Research Collaboration: improving care and treatment for patients with cough

“…Furthermore, there is a need to raise awareness of cough as an important and difficult-to-manage clinical problem in lung diseases including COPD, asthma, IPF and bronchiectasis. The NEUROCOUGH CRC envisages fruitful collaborations with others within the ERS CRC family, including but not limited to EMBARC [34], SHARP [35], CADSET [36] and Ariane-IPF [37].…”

The Severe Paediatric Asthma Collaborative in Europe (SPACE) ERS Clinical Research Collaboration: enhancing participation of children with asthma in therapeutic trials of new biologics and receptor blockers

“…In this respect, the ERS would have a central role, for communication with national societies and ERS researchers/members, for patient engagement through the European Lung Foundation (ELF) and for an independent liaison with industry partners. SPACE will collaborate with a similar ERS CRC in adults: Severe Heterogenous Asthma Research collaboration, Patient-centred (SHARP) [24]. This will hopefully allow SPACE to implement two further goals: to rethink the critical passage from adolescence to adulthood in the management of severe asthma, and to give a deeper attention to patients', especially adolescents', and parents' input, in collaboration also with ELF.…”